CRISPR Therapeutics and ViaCyte, Inc. Announce First Patient Dosed in Phase 1 Clinical Trial of Novel Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes (T1D)
ZUG, Switzerland, and CAMBRIDGE, Mass., and SAN DIEGO, Feb. 02, 2022 (GLOBE NEWSWIRE) — CRISPR…
17th Hong Kong International Wine & Spirits Fair wraps up on a high note with over 8,200 buyers
The 33rd Hong Kong International Optical Fair attracts some 12,000 buyers
TSplus Remote Support 4.3: Faster, Smarter, and More User-Friendly Than Ever
KOCCA’s WelCon Marketplace Expands Global K-Content Collaboration with 2025 Virtual Exchange Event